Actualités 2019
« BACK
Life Sciences - Innovation - 18.07.2019
Innovation - Physics - 03.06.2019
Innovation - Pharmacology - 22.05.2019 
MaaT Pharma expands patent portfolio with three granted patents covering its microbiome restoration biotherapeutic platform
First patents to cover the fundamental processes for accessing the human gut microbiome as biotherapeutics. MaaT Pharma's microbiome sample collection and administration devices receive CE mark for use in collecting and administrating gut-derived samples as biotherapeutics to patients.
Pharmacology - Innovation - 27.02.2019 
CEA-Leti Breakthrough Opens Path To New Vaccine for HIV using Lipid-Nanoparticle-Delivery Technology
Lipidots Platform Strengthens Immune Response to Protein That Is Key to HIV Vaccine; Results Presented in Nature Publishing Group's npj Vaccines GRENOBLE, France - Feb. Leti, a research institute of CEA Tech, in collaboration with CEA's Fundamental Research Division , has developed a new vaccine approach for HIV based on engineered lipid nanoparticles that deliver p24 - a viral protein that is key to an HIV vaccine- and optimize the CpG adjuvant's effect.
Innovation - Physics - 06.02.2019
Innovation
Results 1 - 5 of 5.
Weebit Nano and CEA-Leti to demonstrate brain-inspired neuromorphic demo
The demo enables massively parallel, low-power and low-latency computation abd will be demonstrated at Flash Memory Summit 2019, August 6-8. Weebit Nano (ASX: WBT), the Israel-based semiconductor company seeking to develop and commercialize the next generation of memory technology, and CEA-Leti, a global leader in miniaturization technologies enabling smart, energy-efficient and secure solutions for industry, will demonstrate a new neuromorphic demo able to perform precise object recognition tasks in an energy-efficient manner at Flash Memory Summit 2019.
The demo enables massively parallel, low-power and low-latency computation abd will be demonstrated at Flash Memory Summit 2019, August 6-8. Weebit Nano (ASX: WBT), the Israel-based semiconductor company seeking to develop and commercialize the next generation of memory technology, and CEA-Leti, a global leader in miniaturization technologies enabling smart, energy-efficient and secure solutions for industry, will demonstrate a new neuromorphic demo able to perform precise object recognition tasks in an energy-efficient manner at Flash Memory Summit 2019.
CEA-Leti and Silvaco Team Up!
Project Combines CEA-Leti's Semiconductor Development Expertise and Silvaco's SPICE Simulation and Variability Analysis Technologies LAS VEGAS - June 3, 2019 - Leti, a research institute of CEA-Tech, and Silvaco Inc., a leading global provider of software, IP and services for designing chips and electronic systems for semiconductor companies, today announced, during the 56 th Design Automation Conference (DAC) in Las Vegas, a project to estimate and model the yield of ultra-low-voltage (ULV), ultra-low-leakage (ULL) static random access memory (SRAM) used in computing applications.
Project Combines CEA-Leti's Semiconductor Development Expertise and Silvaco's SPICE Simulation and Variability Analysis Technologies LAS VEGAS - June 3, 2019 - Leti, a research institute of CEA-Tech, and Silvaco Inc., a leading global provider of software, IP and services for designing chips and electronic systems for semiconductor companies, today announced, during the 56 th Design Automation Conference (DAC) in Las Vegas, a project to estimate and model the yield of ultra-low-voltage (ULV), ultra-low-leakage (ULL) static random access memory (SRAM) used in computing applications.
First patents to cover the fundamental processes for accessing the human gut microbiome as biotherapeutics. MaaT Pharma's microbiome sample collection and administration devices receive CE mark for use in collecting and administrating gut-derived samples as biotherapeutics to patients.
Lipidots Platform Strengthens Immune Response to Protein That Is Key to HIV Vaccine; Results Presented in Nature Publishing Group's npj Vaccines GRENOBLE, France - Feb. Leti, a research institute of CEA Tech, in collaboration with CEA's Fundamental Research Division , has developed a new vaccine approach for HIV based on engineered lipid nanoparticles that deliver p24 - a viral protein that is key to an HIV vaccine- and optimize the CpG adjuvant's effect.
CEA-Leti combines integrated optics and holography in novel lens-free, augmented reality technology
Leti, an institute of CEA-Tech, has developed a novel retinal-projection concept for augmented reality (AR) uses based on a combination of integrated optics and holography. The lens-free optical system uses disruptive technologies to overcome the limitations of existing AR glasses, such as limited field-of-view and bulky optical systems.
Leti, an institute of CEA-Tech, has developed a novel retinal-projection concept for augmented reality (AR) uses based on a combination of integrated optics and holography. The lens-free optical system uses disruptive technologies to overcome the limitations of existing AR glasses, such as limited field-of-view and bulky optical systems.
